Form 8-K - Current report:
SEC Accession No. 0001104659-25-098082
Filing Date
2025-10-09
Accepted
2025-10-09 07:09:26
Documents
19
Period of Report
2025-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2528058d2_8k.htm   iXBRL 8-K 48247
2 EXHIBIT 4.1 tm2528058d2_ex4-1.htm EX-4.1 100644
3 EXHIBIT 4.2 tm2528058d2_ex4-2.htm EX-4.2 95609
4 EXHIBIT 10.1 tm2528058d2_ex10-1.htm EX-10.1 315794
5 EXHIBIT 10.2 tm2528058d2_ex10-2.htm EX-10.2 152776
6 EXHIBIT 10.3 tm2528058d2_ex10-3.htm EX-10.3 25901
7 EXHIBIT 99.1 tm2528058d2_ex99-1.htm EX-99.1 13211
11 GRAPHIC tm2528058d2_ex99-1img001.jpg GRAPHIC 12347
  Complete submission text file 0001104659-25-098082.txt   1118207

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA lptx-20251006.xsd EX-101.SCH 3008
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20251006_lab.xml EX-101.LAB 34239
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20251006_pre.xml EX-101.PRE 22354
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2528058d2_8k_htm.xml XML 3686
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 251383606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)